SOURCE: Ingen Technologies, Inc.

Ingen Technologies, Inc.

November 27, 2012 08:15 ET

Grass Roots Research to Issue Favorable Report on Ingen Technologies

Report Expects Company's Revenues to Grow to $2.0 Million in FY-2013 and $50.0 Million by 2018

RIVERSIDE, CA--(Marketwire - Nov 27, 2012) -  Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with patented proprietary technology for the growing $4 billion Respiratory Market is pleased to announce that Grass Roots Research & Distribution Inc. will publish their Research Report on Ingen Technologies Inc. on December 3, 2012. 

"We are pleased to inform our shareholders that the Grass Roots Research Report of Ingen's financial forecasts and valuation will be highlighted. The report will also include a forecast of the Company's revenues, which are expected to grow to $2.0 million in FY-2013 and $50.0 million by 2018. According to the report based on an average of the Cohen Price Performance, IGNT common stock should be valued at $0.15 per share, 1,878.1% higher than the current market price per share. The report goes on to say that the stock is an interesting short-term trade and potentially a good long-term investment," stated Gary B. Tilden, Chairman of the Board.

VISIT OUR WEBSITE AT: www.ingen-tech.com or FACT SHEET AT: http://ingen-tech.com/files/documents/ignt-1112.pdf

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact Information